These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2115575)

  • 1. Medical management of gallstones: a cost-effectiveness analysis.
    Weinstein MC; Coley CM; Richter JM
    J Gen Intern Med; 1990; 5(4):277-84. PubMed ID: 2115575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A computer model for evaluating the costs of cholecystectomy or ursodiol treatment in the management of cholelithiasis.
    Crain K
    Clin Ther; 1990; 12(3):250-62. PubMed ID: 2379230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of ursodiol: the creature from the black box.
    Diehl AK
    J Gen Intern Med; 1990; 5(4):374-5. PubMed ID: 2115578
    [No Abstract]   [Full Text] [Related]  

  • 4. Gallstone dissolution therapy with ursodiol. Patient selection.
    Fromm H
    Dig Dis Sci; 1989 Dec; 34(12 Suppl):36S-38S. PubMed ID: 2598766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expected costs in the conservative and surgical treatment of uncomplicated cholecystolithiasis].
    Sonnenberg A; Leuschner U; Leuschner M
    Z Gastroenterol; 1982 Feb; 20(2):66-77. PubMed ID: 7064499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of ursodiol on the efficacy and safety of extracorporeal shock-wave lithotripsy of gallstones. The Dornier National Biliary Lithotripsy Study.
    Schoenfield LJ; Berci G; Carnovale RL; Casarella W; Caslowitz P; Chumley D; Davis RC; Gillenwater JY; Johnson AC; Jones RS
    N Engl J Med; 1990 Nov; 323(18):1239-45. PubMed ID: 2215608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodiol: a cholesterol gallstone solubilizing agent.
    Rosenbaum CL; Cluxton RJ
    Drug Intell Clin Pharm; 1988 Dec; 22(12):941-5. PubMed ID: 3072172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallstone dissolution therapy with ursodiol. Efficacy and safety.
    Salen G
    Dig Dis Sci; 1989 Dec; 34(12 Suppl):39S-43S. PubMed ID: 2689115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical perspective on the treatment of gallstones with ursodeoxycholic acid.
    Salen G
    J Clin Gastroenterol; 1988; 10 Suppl 2():S12-7. PubMed ID: 3062079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal shock-wave lithotripsy and ursodiol versus ursodiol alone in the treatment of gallstones.
    Ertan A; Hernandez RE; Campeau RJ; Geshner JR; Litwin MS
    Gastroenterology; 1992 Jul; 103(1):311-6. PubMed ID: 1612339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of external shock-wave lithotripsy and adjuvant ursodiol for treatment of radiolucent gallstones. A national multicenter study.
    Burnett D; Ertan A; Jones R; O'Leary JP; Mackie R; Robinson JE; Salen G; Stahlgren L; Van Thiel DH; Vassy L
    Dig Dis Sci; 1989 Jul; 34(7):1011-5. PubMed ID: 2663386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of patients with symptomatic gallstones: a quantitative analysis.
    Ransohoff DF; Gracie WA
    Am J Med; 1990 Feb; 88(2):154-60. PubMed ID: 2405659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gall stone dissolving agents.
    Bouchier IA
    Br Med J (Clin Res Ed); 1983 Mar; 286(6367):778-80. PubMed ID: 6402249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Choice and modalities of the treatment of biliary lithiasis].
    Malè PJ; Meyer P
    Schweiz Med Wochenschr; 1986 Aug; 116(31-32):1040-4. PubMed ID: 3749841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in serum bile acids during treatment with chenodiol or ursodiol for dissolution of cholesterol gallstones.
    Nowak M; Panveliwalla D; Pertsemlidis D
    Mt Sinai J Med; 1983; 50(3):240-4. PubMed ID: 6604868
    [No Abstract]   [Full Text] [Related]  

  • 16. Lithotripsy versus cholecystectomy for management of gallstones. A decision analysis by Markov process.
    Sonnenberg A; Derfus GA; Soergel KH
    Dig Dis Sci; 1991 Jul; 36(7):949-56. PubMed ID: 1906398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A clinical decision analysis to assess therapeutic modalities for symptomatic gallstones with respect to patient's quality of life and cost-effectiveness].
    Habu Y; Matsui T; Hayashi K; Watanabe Y; Kawai K
    Nihon Shokakibyo Gakkai Zasshi; 1993 Nov; 90(11):2895-908. PubMed ID: 8271461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodiol for dissolving cholesterol gallstones.
    Med Lett Drugs Ther; 1988 Aug; 30(773):81-3. PubMed ID: 3043153
    [No Abstract]   [Full Text] [Related]  

  • 19. Advantages of elective surgical treatment of gallstones.
    McSherry CK
    Hepatogastroenterology; 1989 Oct; 36(5):330-2. PubMed ID: 2695447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of extracorporeal shock-wave lithotripsy versus cholecystectomy for symptomatic gallstones.
    Bass EB; Steinberg EP; Pitt HA; Saba GP; Lillemoe KD; Kafonek DR; Gadacz TR; Gordon TA; Anderson GF
    Gastroenterology; 1991 Jul; 101(1):189-99. PubMed ID: 1904378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.